AbbVie Inc. vs CV Sciences, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- AbbVie Inc. is the larger company by market value: $514.0 B against $20 M for CV Sciences, Inc., 25700 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 7, 2022 for CV Sciences, Inc.). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
- AbbVie Inc. had more revenue: $61.2 B against $14 M for CV Sciences, Inc., both in the year to December 2025.
- AbbVie Inc. made a net profit of $4.2 B, while CV Sciences, Inc. made a net loss of $1 M.
- AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -7.0% for CV Sciences, Inc.
- AbbVie Inc. employs more people: 57,000 against 44 at CV Sciences, Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $313,409 at CV Sciences, Inc.
- AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -12.2% for CV Sciences, Inc.
- On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and CV Sciences, Inc. 6.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | AbbVie Inc. ABBV · #26 in the world | CV Sciences, Inc. CVSI |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | 2013 | 2010 |
| Size | ||
| Market cap | $514.0 B | $20 M* |
| Revenue | $61.2 B | $14 M |
| Net income | $4.2 B▲ best | $-1 M |
| Employees | 57,000 | 44 |
| Valuation | ||
| P/E ratio | 49.7× | — |
| Price to sales | 7.8× | — |
| Free cash flow yield | 3.5% | — |
| Profitability | ||
| Gross margin | 70.2%▲ best | 49.0% |
| Operating margin | 24.6%▲ best | -3.4% |
| Net margin | 6.9%▲ best | -7.0% |
| Return on equity | — | -58.7% |
| Return on invested capital | 16.0% | — |
| Growth | ||
| Revenue growth | 8.6%▲ best | -12.2% |
| Revenue growth, 3 years a year | 1.8%▲ best | -5.2% |
| Earnings per share growth | -1.3% | — |
| Financial strength | ||
| Debt to equity | — | 1.1× |
| Interest cover | 5.2× | — |
| Cash | ||
| Free cash flow margin | 29.1%▲ best | -3.8% |
| Shareholder returns | ||
| Dividend yield | 2.3% | — |
| Shareholder yield | 2.5% | — |
| Strength scores | ||
| Piotroski F-score | 8 of 9▲ best | 6 of 9 |
| Altman Z-score zone | grey | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Jan 2022; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, AbbVie Inc. or CV Sciences, Inc.?
AbbVie Inc. is the larger company by market value: $514.0 B against $20 M for CV Sciences, Inc., 25700 times as much (market caps of Oct 30, 2026 for AbbVie Inc. and Jan 7, 2022 for CV Sciences, Inc.). CV Sciences, Inc.'s value is the last on file, from Jan 7, 2022: no market-data feed is connected for its exchange yet.
Which makes more money, AbbVie Inc. or CV Sciences, Inc.?
AbbVie Inc. had more revenue: $61.2 B against $14 M for CV Sciences, Inc., both in the year to December 2025. AbbVie Inc. made a net profit of $4.2 B, while CV Sciences, Inc. made a net loss of $1 M.
Which is more profitable, AbbVie Inc. or CV Sciences, Inc.?
AbbVie Inc. keeps more of each dollar of sales: a net margin of 6.9% against -7.0% for CV Sciences, Inc.
Which has more employees, AbbVie Inc. or CV Sciences, Inc.?
AbbVie Inc. employs more people: 57,000 against 44 at CV Sciences, Inc. Each employee brings in about $1,072,982 of revenue at AbbVie Inc. and $313,409 at CV Sciences, Inc.
Which is growing faster, AbbVie Inc. or CV Sciences, Inc.?
AbbVie Inc.'s revenue grew faster in its latest fiscal year: +8.6% against -12.2% for CV Sciences, Inc.
Which is financially stronger, AbbVie Inc. or CV Sciences, Inc.?
On the Piotroski F-score, a nine-point test of improving finances, AbbVie Inc. scores 8 and CV Sciences, Inc. 6.
More about AbbVie Inc.
More about CV Sciences, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.